跳至主要内容
临床试验/IRCT201502226710N5
IRCT201502226710N5已完成3 期

Effect of high dose versus low dose Atorvastatin therapy on inflammatory & coagulatory factors in type 2 diabetic patients

Vice chancellor for research, Tabriz University of Medical Sciences Daneshgah Square Tabriz0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with type2 diabetes mellitus LDL>70 ; age>18y ;TG<500; patients who don't use or stopped statin use (> 1 mth)
  • Exclusion criteria: type 1 diabetes Mellitus; chronic liver disease(liver enzymes more than 3 time the upper limit of normal , B or C Hepatitis ); renal failure Cr>2;pregnancy;lactation ; Chronic inflammatory diseases such as rheumatic diseases (rheumatoid arthritis and systemic lupus erythematosus); Patients with a history of anti-inflammatory drugs; In case of muscle pain and increased risk of rhabdomyolysis in patients with CPK elevation; unwillingness to participate in the study.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences Daneshgah Square Tabriz

相似试验